Previous Meeting EHDN2020
When: September 11, 2020 Time: 14:00 — 18:15 CET
(uploaded November 10, 2020)
| Recorded sessions: |
— |
|
| Welcome and introduction
Anne Rosser
Astri Arnesen
Patrick Weydt |
|
|
Scientific progress session
- Chair: Lesley Jones
- Function of HTT — Frédéric Saudou
- Somatic expansion of the HTT CAG repeat — Darren Monckton
- HTT phosphorylation and TBK1 — Hilal Lashuel
- Oral HTT-lowering therapy — George McAllister
- Q&A and Discussion
|
|
|
Clinical studies session — PART 1
- Chair: Jean-Marc Burgunder
- An Update from the Tominersen Global Clinical Development Programme — Sarah Tabrizi
- PRECISION HD1 and 2: allele selective targeting of the mutant HTT — Anna Heinzmann
- Shield-HD — Anne Rosser
- Prilenia — Bernhard Landwehrmeyer
- First Human AAV Gene Therapy Clinical Trial in Adults with Early Manifest HD — Ralf Reilmann
|
|
|
Clinical studies session — PART 2
- Chair: Jean-Marc Burgunder
- MIG-HD trial — Anne-Catherine Bachoud-Levi
- HEATED- Huntington’s Equal Access to Effective Drugs — Hugh Rickards
- Q&A and Discussion
|
|
|
| Closing remarks
Bernhard Landwehrmeyer
Anne Rosser |
|
|
